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Abstract  41 
Objectives: We investigated whether a dietary supplement rich in eicosapentaenoic acid 42 
(EPA) increases plasma fasting ketones or postprandial ketone responses in healthy 43 
young and elderly subjects.  44 
Research Methods & Procedures: 10 young (22 ± 2  y old) and 10 elderly subjects (75 ± 45 
4 y old) were recruited and participated in two identical study days, one before and one 46 
6 weeks after providing an EPA-enriched supplement (1.4 g/d of EPA and 0.2 g/d of 47 
docosahexaenoic acid). On the study days, blood samples were collected at fasting and 48 
every hour for 6 h after giving a breakfast. Fasting and post-prandial plasma β-49 
hydroxybutyrate (-OHB), free fatty acids (FFA), triglycerides, glucose and insulin 50 
responses were measured. Fatty acid profiles were assessed in fasting plasma samples 51 
before and after the EPA supplement. 52 
Results: After the EPA supplement, postprandial plasma -OHB responses dropped by 53 
44% in the young and by 24% in the elderly, along with 20% and 34% lower FFA 54 
responses in the young and elderly adults, respectively. -OHB and FFA were positively 55 
and significantly correlated in young but not in elderly subjects both before and after the 56 
EPA supplement. In both groups, postprandial plasma triglycerides, glucose and insulin 57 
were not significantly different after the intake of the EPA supplement. Before and after 58 
the EPA supplement, fasting plasma EPA was 50% higher in the elderly but increased 59 
by about 5 times in both groups following the intake of EPA supplement. 60 
Conclusions: Contrary to our expectations, EPA supplementation lowered postprandial 61 
-OHB response and, in the elderly subjects, the concentration of postprandial -OHB 62 
was not lowered after the intake of EPA supplement.  63 
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Introduction 76 
 Glucose normally provides about 97% of cerebral energy requirements but when 77 
glucose availability is limited, i.e. during fasting or starvation, ketones become important 78 
brain energy substrates supplying up to 70% of brain energy requirements [1]. Brain 79 
uptake of ketones is directly proportional to their circulating level [2-4]. During healthy 80 
aging, brain glucose uptake decreases significantly in specific cortical regions [5], an 81 
effect that is more pronounced in elderly with deteriorating cognitive function such as 82 
Alzheimer’s disease [6]. Therefore, the idea of safely inducing chronic, mild ketonemia 83 
has been proposed as a strategy to counteract declining brain glucose uptake and 84 
hence hopefully reduce the risk of deteriorating cognition in the elderly [7, 8].  85 
Ketones refer to three molecules: acetoacetate, -hydroxybutyrate (-OHB) and 86 
acetone. They are produced principally in liver mitochondria from successive 87 
condensation of acetyl-CoAs derived from -oxidation of free fatty acids (FFA). Despite 88 
the possible need for a fuel to replace glucose in the aging brain, neither of the common 89 
ways of increasing ketone production, i.e. fasting for several days [1] or a very high fat 90 
ketogenic diet [9], seems realistic for the elderly. An alternative approach to safely 91 
inducing mild ketonemia may be to increase FFA -oxidation and up-regulate 92 
transcription of enzymes involved in ketogenesis, particularly 3-hydroxy-3-methylglutaryl 93 
coenzyme A synthase. Both -oxidation and transcription of 3-hydroxy-3-methylglutaryl 94 
coenzyme A synthase are regulated by the nuclear receptor - peroxisome proliferator-95 
activated receptor-alpha (PPAR-), which is a ligand-activated transcription factor [10].  96 
In vitro studies show that the omega-3 fatty acid – eicosapentaenoic acid (EPA; 97 
20:53) – is a strong natural fatty acid ligand for PPAR-[11]. Hence, our hypothesis 98 
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was that if PPAR- is involved in activating the -oxidation of FFA and up-regulating 99 
enzymes of ketogenesis and since EPA is a good ligand of PPAR- [11], ketogenesis 100 
should increase after consuming an EPA supplement. Until now, the possible link 101 
between activation of PPAR- by fatty acids such as EPA and increased ketogenesis 102 
had not been assessed in humans. The aims of this study were to determine, first, 103 
whether supplementation with an EPA-enriched fish oil would increase ketone 104 
concentration and, second, whether ketone concentration would differ in the elderly 105 
compared to young adults after EPA supplementation.  106 
Given the potentially important clinical application of ketones as alternative 107 
cerebral energy substrates in the elderly, but the relative scarcity of information about 108 
fasting and postprandial ketone production during healthy aging [12], we compared 109 
these parameters in healthy elderly to young adults after giving an EPA supplement. Our 110 
approach was to measure changes in plasma FFA and ketone concentration during two 111 
identical metabolic study days, one before and one 6 wk after EPA supplementation 112 
since a direct measure of ketogenesis enzymes and PPAR- activation was not possible 113 
in human liver. 114 
115 
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Subjects and Methods 116 
Subjects: Subjects were recruited in two age groups: 18-25 y old (young) and 70-85 y 117 
old (elderly). All subjects were non-smokers and selected for relatively good health. As 118 
part of the screening, blood chemistry was assessed after a 12 h overnight fast. Fasting 119 
glucose and hemoglobin A1c were used to rule out the presence of glucose intolerance 120 
or overt diabetes. A complete blood cell count was used for blood disorders, electrolyte 121 
profile, aspartate transaminase and alanine transaminase for liver function/nutritional 122 
status, high and low density lipoprotein cholesterol, triglycerides and albumin for 123 
nutritional status, C-reactive protein as a marker of inflammatory processes, and thyroid 124 
stimulating hormone for thyroid function. Subjects with plasma omega-3 fatty acids 125 
higher than 4% of total fatty acids were excluded. Except for glucose and cholesterol, 126 
other parameters did not differ significantly between the two groups (Table 1).  127 
Approval for the study was obtained from the Research Ethics Committee of the 128 
Health and Social Services Center – Sherbrooke University Geriatrics Institute, which 129 
oversees all human research done at the Research Center on Aging. All subjects gave 130 
informed, written consent before participating. Thirty subjects underwent screening. 131 
Complete metabolic data were obtained for 10 young and 10 elderly subjects (5 women 132 
and 5 men in each group) who met our inclusion criteria. A group size of ten was 133 
sufficient to meet the statistical power ( = 0.80) needed to achieve a significant 134 
difference in doubling fasting plasma ketones after EPA supplementation [13].  135 
 136 
Protocol and sample collection: During the study, each subject consumed 4 capsules / 137 
day providing a total of 1480 mg/d of EPA and 250 mg/d of docosahexaenoic acid (DHA; 138 
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22:63). The capsules used were a commercially-available omega-3 fatty acid 139 
supplement (OM3, Isodis Natura, Brussels, Belgium), hereafter designated as the EPA 140 
supplement. Subjects participated in two identical metabolic study days, one before and 141 
one 6 wk after EPA supplementation. On each metabolic study day, subjects arrived at 142 
7:30 a.m. after a 12 h fast. A forearm venous catheter was installed and was kept patent 143 
by flushing hourly with non-heparinized saline after fasting blood draw (defined as time 144 
0) and hourly blood draw for 6 h using a 5 ml latex-free syringe (Becton Dickinson, 145 
Franklin Lakes, NJ). The subjects received a breakfast (between time 0 and time 1) 146 
composed of eggs, bacon, cheese, one slice of tomato and toast with an average fat 147 
content of 23 g or 43% of the breakfast calories and around 38 g of carbohydrates 148 
accounting for around 34% of the breakfast calories. Blood samples were transferred 149 
immediately to a 5 mL K2-EDTA coated tube (Becton Dickinson) and kept on ice until the 150 
end of the study day when they were all centrifuged at 2300 g for 18 min at 4˚C. Plasma 151 
was stored at -20˚C until further analysis. During the study day, water was available ad 152 
libitum and subjects were asked to remain in a resting position, with short walks allowed. 153 
 154 
Plasma fatty acid profile: Plasma total lipids were extracted into 2:1 chloroform/methanol 155 
solution, using heptadecanoate as an internal standard. The total lipids were then 156 
saponified with 1 mol/L methanolic potassium hydroxide followed by transmethylation of 157 
the FFA to fatty acid methyl esters using 14% methanolic boron trifluoride. Fatty acid 158 
methyl esters were analyzed using a gas chromatograph (Agilent model 6890, Palo Alto, 159 
CA) equipped with a 50 m BPX-70 fused capillary column (SGE, Melbourne, Australia, 160 
0.25 mm i.d., 0.25 m film thickness). Splitless mode injection and flame ionization 161 
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detection were performed at 250°C. The oven temperature program was 50°C for 2 min, 162 
increased to 170°C at a rate of 20°C/min and held there for 15 min, increased to 210°C 163 
at a rate of 5°C/min and held there for 7 minutes. The inlet pressure of the carrier gas 164 
(He) was 233 kPa at 50°C. The identity of individual fatty acids was determined by 165 
comparing retention times with standard mixtures of fatty acids (NuChek 68A, NuChek 166 
411, and NuChek 455; NuChek Prep, Inc., Elysian, MN) and a custom mixture of 167 
saturated fatty acid standards. 168 
 169 
Other analyses: Commercially available reagent kits were used for the analysis of -170 
OHB (RX Daytona kit; Randox Laboratories Ltd., Antrim, UK), and FFA (Wako 171 
Diagnostics, Richmond, VA) and triglycerides and glucose (Dade Behring Inc., Newark, 172 
DE) using an automated clinical chemistry analyzer (Dimension XPand Plus, Dade 173 
Behring Inc., Newark, DE). Insulin was analyzed by ELISA (Mercodia, Upssala, Sweden) 174 
using a microplate reader (model 3550, BioRad, Hercules, CA). 175 
 176 
Statistical analysis: Results are given as mean ± SEM in Figures and Tables. 177 
Postprandial responses over the 6 h of the study day were defined by areas under the 178 
curve calculated for plasma -OHB, FFA, triglycerides, glucose and insulin (Prism 179 
software version 4.0, GraphPad Prism, San Diego, CA) allowing comparison between 180 
curves. Since data were not normally distributed and the sample size was small, we 181 
used non-parametric tests to compare data. Hence, data for the two age groups were 182 
compared by a Mann-Whitney test using SPSS software (version 12.0, SPSS Inc, 183 
Chicago, IL). To determine statistical significance following the EPA supplementation, 184 
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we used Wilcoxon’s signed rank test. To determine age-by-diet interactions, we 185 
compared calculated variables (after – before EPA supplement) for fasting -OHB, FFA, 186 
triglycerides, glucose and insulin and for postprandial responses between age groups 187 
using a Mann-Whitney test. Correlation between FFA and -OHB was determined using 188 
the Spearman correlation coefficient. Significance was set at p < 0.05.  189 
190 
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Results 191 
Plasma-OHB and FFA (Figure 1): After the EPA supplement, fasting plasma -OHB 192 
and FFA were respectively 51% lower (p = 0.007) and 35% lower (p = 0.022) in young 193 
subjects but unchanged in the elderly. Postprandial -OHB response was significantly 194 
lower in both groups after the EPA supplement, with a greater drop (44%) in the young 195 
than in the elderly (24%). Similarly, after EPA, the postprandial FFA response was 20% 196 
lower in both groups, but did not reach statistical significance in the young subjects (p = 197 
0.059). Neither before nor after EPA was -OHB response statistically different between 198 
elderly and young subjects. In contrast, the postprandial FFA response was about 40% 199 
higher in the elderly both before (p = 0.014) and after (p = 0.013) the EPA supplement. 200 
Fasting plasma FFA and -OHB were positively correlated in young (p < 0.05) both 201 
before and after the intake of EPA supplement but not in elderly (Figure 2).  202 
 203 
Plasma triglycerides, glucose and insulin (Figure 1): Before EPA supplementation, 204 
fasting plasma triglycerides were similar in the young and the elderly. After EPA 205 
supplementation, the elderly had 63% higher fasting triglycerides compared to the young 206 
adults (p = 0.041) and postprandial plasma triglycerides levels were significantly higher 207 
compared to young (p = 0.041). In both groups, fasting and postprandial plasma 208 
triglycerides were not significantly lower after the EPA supplement. In the elderly, fasting 209 
glucose was around 24% higher both before and after EPA supplementation compared 210 
to young. In both groups, fasting glucose concentrations and postprandial glucose 211 
responses were similar after the intake of EPA supplement. Fasting and postprandial 212 
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insulin of elderly was similar to young before and after the EPA supplementation. After 213 
EPA supplementation, fasting plasma insulin was 42% and 39% higher in the elderly (p 214 
= 0.017) and the young (p = 0.114), respectively whereas the postprandial insulin 215 
response was not significantly different in both groups.  216 
 217 
Plasma fatty acid profile (Figure 4): Plasma fatty acid profiles were assessed to evaluate 218 
the effectiveness of the EPA supplement in increasing fasting plasma EPA and DHA 219 
levels. Before EPA supplementation and compared to the young adults, the elderly had 220 
85% higher plasma EPA but DHA concentration was similar in both groups. After the 221 
intake of EPA supplement, fasting plasma EPA concentration was 5.6 and 5.1 times 222 
higher in the young and elderly, respectively, whereas fasting plasma DHA was 24% 223 
higher only in the young subjects (p = 0.037). After the EPA supplement, fasting plasma 224 
EPA (mg/L) remained 67% higher in elderly compared to young adults.  225 
226 
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Discussion 227 
This study aimed to evaluate the impact of EPA supplementation on fasting and 228 
postprandial ketone concentration in both young and elderly adults. Our results suggest 229 
that EPA supplementation reduced the postprandial -OHB and FFA responses in both 230 
groups. The concentration of ketones in plasma reflects the balance between 231 
appearance in and removal from the plasma. Although -oxidation of -OHB is similar in 232 
young and elderly adults [12], we have no indication whether after an EPA 233 
supplementation the -oxidation of -OHB would be higher or its removal from plasma 234 
would be altered. Therefore, the reason why EPA supplementation lowered rather than 235 
raised -OHB and FFA responses in this study is unclear.  236 
The production of ketones requires increased mobilization of FFA from adipose 237 
tissue to the liver by increasing lipolysis in adipose tissue and/or triglyceride-rich 238 
lipoproteins [14, 15], coupled with enhancement of the liver's capacity to convert these 239 
substrates into -OHB and other ketones [16]. Since we observed a linear correlation 240 
between fasting plasma FFA and -OHB concentrations in young subjects (Figure 2) 241 
[14] and because ketones are produced from FFA -oxidation, the lower FFA response 242 
may therefore have contributed significantly to lowered -OHB response (Figure 1).  243 
Indeed, we hypothesized that giving an EPA supplement would up-regulate 244 
ketogenesis enzymes in the liver leading to increase ketone concentration. However, 245 
EPA interacts with at least four families of transcription factors - PPAR-, liver X 246 
receptors, hepatic nuclear factor-4 and sterol regulatory-element-binding protein - and 247 
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generates a large range of eicosanoids able to modulate transcription factor activity [17]. 248 
It is therefore possible that the EPA supplement may have simultaneously decreased 249 
lipolysis through one of the other activated transcription factors since it is controlled by 250 
gene transcription in the liver [18]. Two studies in humans [14, 19], reported that an EPA 251 
supplement resulted in decreased peripheral lipolysis from adipose tissue thereby 252 
reducing the availability of FFA. Moreover, EPA is suggested to lower liver TG synthesis 253 
and increase adipose TG clearance thereby reducing the release of FFA by lipoprotein 254 
lipase [17]. In this study, EPA supplementation did not significantly lower fasting or 255 
postprandial plasma TG (Figure 3). This result may not be so unusual in normolipidic 256 
humans since it occurs in about half of placebo-controlled trials [20] and is due to low 257 
baseline TG concentration and EPA dose [17]. Hence, increasing plasma -OHB 258 
concentrations in humans appears complex and may require combined strategies for 259 
increasing FFA lipolysis (substrate for ketonegenesis) from either adipose tissue and/or 260 
triglyceride-rich lipoproteins while simultaneously increasing the liver’s capacity to 261 
produce ketones. 262 
Since cognitive decline affects the elderly and because ketones are the major 263 
alternative brain fuel to glucose, we investigated whether fasting and postprandial 264 
ketone concentrations would be increased similarly in young and elderly after the EPA 265 
supplementation. In our elderly group, neither fasting nor postprandial plasma -OHB 266 
was statistically different from that seen in our young adults but the elderly had a higher 267 
postprandial FFA response compared to our young subjects. Moreover, our data do not 268 
support a significant correlation of fasting plasma FFA with -OHB in the elderly either 269 
before or after EPA supplementation (Figure 2). Therefore, lipid metabolism, specifically 270 
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regarding FFA release and/or -oxidation, is possibly altered during aging [22]. 271 
However, the ratio of fasting plasma -OHB/FFA, which is suggested to be a marker for 272 
fatty acid -oxidation capacity and/or ketogenesis in the liver [14], was not statistically 273 
different between young and elderly (data not shown).  274 
Thus, the higher postprandial response of FFA in the elderly (Figure 1) [22] may 275 
be a result of lower -oxidation in muscle possibly resulting from lower muscle mass in 276 
elderly or lower muscle capacity for -oxidation [22]. Despite possibly altered lipid 277 
metabolism in the elderly, our results support a similar concentration of both fasting and 278 
postprandial -OHB response in elderly compared to young adults.  279 
EPA incorporation into plasma lipids following an EPA supplementation may differ 280 
during aging [23, 24]. In this study, fasting plasma EPA concentration before EPA 281 
supplementation was 85% higher in our elderly compared to young adults, which agrees 282 
with previous work [23, 24]. The reasons why plasma EPA differs in the young and 283 
elderly is unknown [23] but may result from lower -oxidation of dietary EPA, thus 284 
leaving a greater proportion for incorporation into plasma lipids in the elderly [24]. The 285 
impact of higher incorporation of EPA into plasma lipids during aging has not yet been 286 
fully investigated but should be considered as a possible confounder in results of studies 287 
using fish oil supplementation with elderly. Our EPA supplement also provided 200 mg 288 
of DHA/d, but this did not significantly raise fasting plasma DHA in our elderly group. 289 
This indirectly suggests that 200 mg of DHA/d for 6 wk may not be sufficient to raise 290 
fasting plasma DHA in the elderly.  291 
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We conclude that short term EPA supplementation lowers -OHB and FFA 292 
responses, an effect apparently not influenced by healthy aging.  293 
 294 
295 
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Figure Legends 361 
Figure 1: Plasma -hydroxybutyrate (-OHB, upper, mean  SEM) and free fatty acid 362 
(FFA, lower) postprandial responses of young and elderly before and 6 wk after the 363 
intake of eicosapentaenoic acid (EPA) supplement. Subjects had breakfast between 364 
time 0 and time 1 (↑).  365 
*Statistically different for fasting plasma measures, p < 0.05. 366 
† Area under the curves significantly decreased after EPA supplement, p < 0.05 367 
 368 
Figure 2: Correlation between fasting plasma -hydroxybutyrate (-OHB) and free fatty 369 
acids (FFA) in young and elderly before and 6 weeks after the intake of 370 
eicosapentaenoic acid (EPA) supplement. Both correlations in young were statistically 371 
significant (p < 0.05) while both correlations in elderly were not statistically significant.  372 
 373 
Figure 3: Concentration (mg/L) of fasting plasma eicosapentaenoic acid (EPA), and 374 
docosahexaenoic acid (DHA) in young and elderly before and 6 weeks after the intake of 375 
EPA supplement. 376 
*Statistically significant between young and elderly on same EPA treatment, p < 0.05 377 
† Significantly increased after EPA supplement, p < 0.05 378 
 379 
Figure 1: Plasma triglycerides (upper, mean  SEM), glucose (middle) and insulin 380 
(lower) postprandial responses of young and elderly before and 6 wk after the intake of 381 
B 
B 
Plourde et al., page 22 
eicosapentaenoic acid (EPA) supplement. Subjects had breakfast between time 0 and 382 
time 1 (↑).  383 
*Statistically different for fasting plasma measures, p < 0.05. 384 
 385 
